About TELOMIR PHARMACEUTICALS, INC.
Telomir Pharmaceuticals is a clinical-stage biotechnology company developing first-in-class small-molecule therapeutics targeting epigenetic and metabolic pathways implicated in cancer and age-related disease. Its lead investigational candidate, Telomir-Zn, is designed to restore epigenetic regulation associated with tumor progression, genomic instability, and treatment resistance.
Development of first-in-class small-molecule therapeuticsTargeting epigenetic and metabolic pathways in cancer and age-related diseaseClinical evaluation of Telomir-Zn in triple-negative breast cancer (TNBC)
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to TELOMIR PHARMACEUTICALS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.